BCAT1 controls metabolic reprogramming in activated human macrophages and is associated with inflammatory diseases

BCAT1 controls metabolic reprogramming in activated human macrophages and is associated with inflammatory diseases

BCATs catabolize leucine and other BCAAs. Here the authors show that BCAA metabolism affects the broken Krebs cycle, reprogramming macrophages to be less proinflammatory, and show that BCAT1 inhibitor ERG240 can treat arthritis in mice and glomerulonephritis in rats.

Guardado en:
Detalles Bibliográficos
Autores principales: Adonia E. Papathanassiu, Jeong-Hun Ko, Martha Imprialou, Marta Bagnati, Prashant K. Srivastava, Hong A. Vu, Danilo Cucchi, Stephen P. McAdoo, Elitsa A. Ananieva, Claudio Mauro, Jacques Behmoaras
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
Science
Q
Acceso en línea:https://doaj.org/article/17c2e0ed5041454ca875e7539e4aa551
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/17c2e0ed5041454ca875e7539e4aa551

Ejemplares similares